Medicine & Life Sciences
Orthomyxoviridae
100%
HIV
69%
Viruses
66%
Influenza A virus
54%
Hemagglutinins
44%
Human Influenza
42%
HIV-1
42%
Coronavirus
42%
Pandemics
40%
Infections
38%
Vaccines
35%
Interferons
33%
Virus Diseases
33%
Antiviral Agents
32%
Influenza Vaccines
30%
Severe Acute Respiratory Syndrome
26%
Antibodies
25%
SARS Virus
23%
Proteins
22%
Newcastle disease virus
20%
Acquired Immunodeficiency Syndrome
19%
Vaccination
18%
HIV Infections
18%
RNA
18%
T-Lymphocytes
17%
Hepacivirus
17%
Neuraminidase
16%
Influenza B virus
16%
H1N1 Subtype Influenza A Virus
15%
Virulence
14%
Genes
14%
Therapeutics
14%
Interferon Type I
14%
Innate Immunity
13%
Immunity
13%
influenza virus INS1 protein
13%
Transplant Recipients
11%
Epitopes
11%
Mutation
11%
Viral RNA
10%
RNA Viruses
10%
Antibody Formation
10%
Virus Replication
10%
Genome
10%
Virion
9%
Dendritic Cells
9%
Mortality
9%
Transplants
9%
Neutralizing Antibodies
9%
Sexual and Gender Minorities
9%
Pharmaceutical Preparations
8%
Lung
8%
Immunization
8%
Influenza in Birds
8%
Neoplasms
8%
Disease Outbreaks
7%
Monoclonal Antibodies
7%
Nucleoproteins
7%
Reverse Genetics
7%
Communicable Diseases
7%
Population
7%
Yersinia enterocolitica
7%
Zika Virus
7%
Ferrets
7%
Bacteremia
6%
Viral Proteins
6%
Incidence
6%
Antigens
6%
Hepatitis C
6%
Inactivated Vaccines
6%
Viral Load
6%
Attenuated Vaccines
6%
Swine
6%
CD4 Lymphocyte Count
6%
In Vitro Techniques
6%
Epidemics
5%
Liver Transplantation
5%
Serum
5%
Messenger RNA
5%
H7N9 Subtype Influenza A Virus
5%
Epidemiology
5%
Guinea Pigs
5%
Orthomyxoviridae Infections
5%
Vesicular Stomatitis
5%
Safety
5%
Squamous Intraepithelial Lesions
5%
Lung Neoplasms
5%
H5N1 Subtype Influenza A Virus
5%
Immunoglobulin G
5%
Anti-Bacterial Agents
5%
Coinfection
5%
Clinical Trials
5%
B-Lymphocytes
5%
Drug Users
5%
Tissue Donors
5%
Agriculture & Biology
Orthomyxoviridae
48%
Influenza A virus
34%
viruses
25%
hemagglutinins
21%
interferons
19%
Human immunodeficiency virus 1
19%
infection
15%
pandemic
15%
influenza
13%
proteins
12%
vaccines
11%
mice
10%
Influenza B virus
10%
influenza vaccines
9%
antibodies
9%
RNA
7%
Avian orthoavulavirus 1
6%
Severe acute respiratory syndrome coronavirus
6%
cells
6%
sialidase
6%
T-lymphocytes
6%
mutation
6%
virus replication
6%
vaccination
5%